PMC:7464116 / 27036-27202
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T173","span":{"begin":105,"end":110},"obj":"Body_part"},{"id":"T174","span":{"begin":129,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A173","pred":"fma_id","subj":"T173","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A174","pred":"fma_id","subj":"T174","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}
LitCovid-PD-UBERON
{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T70","span":{"begin":105,"end":110},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"uberon_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T301","span":{"begin":34,"end":42},"obj":"Disease"}],"attributes":[{"id":"A301","pred":"mondo_id","subj":"T301","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T64","span":{"begin":129,"end":131},"obj":"Chemical"},{"id":"T66","span":{"begin":144,"end":147},"obj":"Chemical"}],"attributes":[{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A65","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A66","pred":"chebi_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/CHEBI_52999"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T164","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"824","span":{"begin":129,"end":133},"obj":"Gene"},{"id":"825","span":{"begin":144,"end":149},"obj":"Gene"},{"id":"833","span":{"begin":43,"end":51},"obj":"Species"},{"id":"836","span":{"begin":34,"end":42},"obj":"Disease"}],"attributes":[{"id":"A824","pred":"tao:has_database_id","subj":"824","obj":"Gene:3569"},{"id":"A825","pred":"tao:has_database_id","subj":"825","obj":"Gene:3458"},{"id":"A833","pred":"tao:has_database_id","subj":"833","obj":"Tax:9606"},{"id":"A836","pred":"tao:has_database_id","subj":"836","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another important finding is that COVID-19 patients with more severe clinical manifestations have higher serum concentrations of IL-6 and lower IFN-γ than mild forms."}